Heart medication converts cancer cells into vaccine

Heart medication converts cancer cells into vaccine
A class of heart medications, cardiac glycosides, can induce immunogenic cell death, whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according to a study published in the July 18 issue of Science Translational Medicine.

(HealthDay) -- A class of heart medications, cardiac glycosides, can induce immunogenic cell death (ICD), whereby dying cancer cells are converted into a vaccine that stimulates antitumor response, according to a study published in the July 18 issue of Science Translational Medicine.

Laurie Menger, from INSERM U848 in Villejuif, France, and colleagues developed and used an automated epifluorescence microscopy-based platform to identify inducers of ICD.

The researchers found that cardiac glycosides were potent inducers of ICD, and this effect correlated with inhibition of sodium and potassium-dependent adenosine triphosphatase. Their anti-cancer effect was observed in combination with DNA-damaging agents only in immunocompetent mice, and cancer cells treated with chemotherapy and cardiac glycosides were effective as a vaccine in mice challenged with live of the same type. In addition, a retrospective analysis of 145 cancer patients treated with a cardiac glycoside and 290 cancer patients who did not receive the drug showed improved five-year survival in patients treated with the cardiac glycoside (hazard ratio, 0.62).

"It will be interesting to determine the ICD-inducing capacity of large collections of to identify new drugs that elicit an immunological bystander effect," Menger and colleagues write. "Moreover, in the pipeline of drug discovery, it might be advisable to decide on the clinical development of compounds that share target and mechanism of action based on their (perhaps differential) ICD-stimulatory capacity."

Several of the authors hold a patent related to the study.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Certain heart meds may give chemo a boost

date Jul 18, 2012

(HealthDay) -- When common heart drugs such as digitalis and digoxin are combined with some chemotherapy drugs, the effect appears to be an increase in the death of cancer cells, according to French researchers.

Are ICDs up to par with patients living longer?

date Apr 04, 2011

Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with hereditary heart disease ...

Heart drugs show promise for fighting colon cancer

date Dec 16, 2009

Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products. Colon cancer ...

Recommended for you

Merck drug Keytruda effective against 3 cancers

date 2 hours ago

One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer ...

DNA blood test detects lung cancer mutations

date Apr 17, 2015

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.